Risk and benefit of drug use during pregnancy

International Journal of Medical Sciences

Volumn 2, Issue 3, 2005, Pages 100-106

  Bánhidy, Ferenc ^a   Lowry, R Brian ^b   Czeizel, Andrew E ^c,d  

^a SEMMELWEIS UNIVERSITY   (Hungary)

^b UNIVERSITY OF CALGARY   (Canada)

^c FOUNDATION FOR THE COMMUNITY CONTROL OF HEREDITARY DISEASES   (Hungary)

^d Torokvesz lejto 32   (Hungary)

Author keywords

Congenital abnormalities; Congenital abnormality; Critical period; Human teratogenic drugs; Preventive effect of drugs; Recall bias

Indexed keywords

ALCOHOL; AMINOGLYCOSIDE ANTIBIOTIC AGENT; ANDROGEN; BARBITAL; BENZODIAZEPINE; CHLOROTHIAZIDE; CLOMIFENE; COUMARIN DERIVATIVE; DIAZEPAM; DIETHYLSTILBESTROL; ERGOTAMINE DERIVATIVE; ESTROGEN; ETRETINATE; FLURAZEPAM; FUROSEMIDE; ISOTRETINOIN; ORAL CONTRACEPTIVE AGENT; OXYTETRACYCLINE; PENICILLAMINE; POTASSIUM IODIDE; POVIDONE IODINE; QUAZEPAM; RETINOL; SEX HORMONE; TEMAZEPAM; TERATOGENIC AGENT; TETRACYCLINE; THALIDOMIDE; TRIAZOLAM; UNINDEXED DRUG;

ACNE; CASE CONTROL STUDY; CONGENITAL DISORDER; CONGENITAL MALFORMATION; CUTIS LAXA; DIABETES MELLITUS; DRUG MEGADOSE; DRUG USE; ENVIRONMENTAL FACTOR; FETOTOXICITY; FETUS RISK; FIRST TRIMESTER PREGNANCY; GESTATION PERIOD; GOITER; HUMAN; HYPERTHERMIA; LEPROSY; LIMB DEFECT; MATERNAL DISEASE; PREGNANCY; PSORIASIS; REVIEW; RISK BENEFIT ANALYSIS; SIDE EFFECT; SYNDROME; TERATOGENESIS; THROMBOSIS; TOOTH COLOR; WILSON DISEASE;

EID: 23044494023     PISSN: 14491907     EISSN: 14491907     Source Type: Journal    
DOI: 10.7150/ijms.2.100     Document Type: Review

References (52)

1. Jones KL, Smith DW, Ulleland CL. et al. Pattern of malformations in offspring of chronic alcoholic mothers. Lancet. 1973 1 :1267-1267
2. Abel EL. Fetal Alcohol Syndrome and Fetal Alcohol Effects. New York: Plenum Press. 1983
3. Czeizel AE, Kodaj I, Lenz W. Smoking during pregnancy and congenital limb deficiency. Brit Med J. 1994 308 :1473-1476
4. Martinez-Friaz ML, Czeizel AE, Rodriquez-Pinilla E, Bermejo E. Smoking during pregnancy and Poland sequence: Results of a population-based registry and a case-control registry. Teratology. 1999 59 :35-38
5. Hwang SJ, Beaty TH, Panny SR. et al. Association study of transforming growth factor alpha (TGF-alpha) Tag1 polymorphism and oral clefts: indication of geneenvironment interaction in a population-based sample of infants with birth defects. Am J Epidemiol. 1995 141 :629-636
6. Harada Y. Congenital Minimata disease. Minimata Disease Study Group of Minimata Disease. Japan: Kumamoto University. 1968 :93-117
7. Czeizel AE. Drug exposure in pregnant women. Lupus. 2004 13 :740-745
8. Lacroix I, Damase-Michel C, Lapeyre-Mestre M, Monastruc JL. Prescription of drugs during pregnancy in France. Lancet. 2000 42 :1735-1736
9. Briggs GG, Freeman RK, Yaffe SJ. Drugs in Pregnancy and Lactation, 5th ed. Baltimore: Wilkins and Wilkin. 1998
10. Czeizel AE, Keller I, Bod M. An aetiological evaluation of increased occurrence of congenital limb reduction abnormalities in Hungary, 1975-1978. Int J Epid. 1983 12 :445-449
11. Czeizel AE, Rockenbauer M, Siffel Cs, Varga E. Description and mission evaluation of the Hungarian Case-Control Surveillance of Congenital Abnormalities, 1980-1996. Teratology. 2001 63 :176-185
12. Czeizel AE, Erös E, Rockenbauer M. et al. Shortterm oral diazepam treatment during pregnancy. A population-based teratological case-control study. Clin Drug Invest. 2003 23 :451-462
13. Czeizel AE, Rockenbauer M, Sorensen HT, Olsen J. A population-based case-control study of oral chlordiazepoxide use during pregnancy and risk of congenital abnormalities. Neurotox Terat. 2004 26 :593-598
14. Eros E, Czeizel AE, Rockenbauer M. et al. A population-based case-control teratologic study of nitrazepam, medazepam, tofisopam, alprazolum and clonazepam treatment during pregnancy. Eur J Obstet Gynec Reprod Biol. 2002 101 :147-154
15. Czeizel AE. Lack of evidence of teratogenicity of benzodiazepine drugs in Hungary. Reprod Toxicol. 1988 1 :183-188
16. Czeizel AE, Tomcsik M, Timár L. Teratologic evaluation of 178 infants born to mothers who attempted suicide by drugs during pregnancy. Obstet Gynec. 1997 90 :195-201
17. Czeizel AE, Bod M, Halász P. Evaluation of anticonvulsant drugs during pregnancy in a population-based Hungarian study. Eur J Epid. 1992 8 :122-127
18. Czeizel AE, Rockenbauer M. A population-based case-control teratological study of furosemide treatment during pregnancy. Clin Drug Invest. 1999 18 :307-315
19. Czeizel AE, Rockenbauer M, Olsen J, Sorensen HT. A teratological study of aminoglycoside antibiotic treatment during pregnancy. Scand J Infect Dis. 2000 32 :309-313
20. Czeizel AE, Kazy Z, Vargha P. Vaginal treatment with povidone-iodine suppositories during pregnancy. Int J Gynec Obstet. 2004 84 :83-85
21. FASS (Swedish System of Approved Drugs). Classification of medical products for use during pregnancy and lactation: The Swedish System. Stockholm: Drug Information Ltd. 1993
22. Australian Drug Evaluation Committee. Medicines in Pregnancy: An Australian Categorization of Risk. Canberra, Australia: AGPS. 1992
23. Czeizel AE, Rockenbauer M. A population-based case-control study of oral oxytetracycline treatment during pregnancy. Eur J Obstet Gynec Reprod Biol. 2000 88 :27-33
24. Czeizel AE, Rockenbauer M. Teratogenic study of doxycycline. Obstet Gynec. 1997 89 :524-528
25. Czeizel AE, Rockenbauer M. Prevention of congenital abnormalities by vitamin A. Internat J Vit Nutr. 1998 68 :219-231
26. Mastroiacovo P, Mazzone T, Addis A. et al. High vitamin A intake in early pregnancy and major malformations: A multicenter prospective controlled study. Teratology. 1999 59 :7-11
27. Czeizel AE. The first trimester concept is outdated (Editorial). Congen Anom. 2001 41 :204-
28. Czeizel AE, Telegdi L, Tusnady G. Multiple Congenital Abnormalities. Budapest: Akadémiai Kiadó. 1988
29. Czeizel AE. Prevention of oral clefts through the use of folic acid and multivitamin supplements: evidence and gaps. In: (ed.) Wyszinski DF. Cleft Lip and Palate: From Origin to Treatment. New York: Oxford University Press. 2002 :443-457
30. Czeizel AE, Puho E, Sorensen HT, Olsen J. Possible association between different congenital abnormalities and use of different sulfonamides during pregnancy. Congen Anom. 2004 44 :79-86
31. Czeizel AE, Rockenbauer M. A population-based case-control teratologic study of oral metronidazole treatment during pregnancy. Brit J Obstet Gynec. 1998 105 :322-327
32. Czeizel AE, Kazy Z, Puho E. A population-based case-control teratologic study of topical miconazole. Congen Anom. 2004 44 :41-45
33. Kazy Z, Puho E, Czeizel AE. The possible association between the combination of vaginal metronidazole and miconazole treatment and poly-syndactyly. Populationbased case-control teratologic study. Reprod Toxic. 2005 20 :89-94
34. Czeizel AE, Puho E, Bánhidy F, Ács N. Oral pyridoxine during pregnancy. Potential protective effect for cardiovascular malformations. Clin Drug Invest. 2004 5 :259-269
35. Rockenbauer M, Czeizel AE, Olsen J. et al. Recall bias in a case-control surveillance system on the use of medicine during pregnancy. Epidemiology. 2001 12 :461-466
36. Czeizel AE, Petik D, Vargha P. Validation studies of drug exposures in pregnant women. Pharmacoepid Drug Safety. 2003 12 :409-416
37. de Vries Cs, de Valle HEK, Cornel MC, de Jong-van den Berg. Registration of drug use in a birth defect monitoring system: a priority worthy of emphasis. Int J Risk Safety in Medicine. 1993 4 :27-34
38. Acs N, Bánhidy F, Puho E, Czeizel AE. Population-based case-control study of influenza during pregnancy for congenital abnormalities. Birth Defects Research (Part A). submitted
39. Acs N, Bánhidy F, Puho E, Czeizel AE. Population-based case-control study of acute infectious diseases of respiratory system for congenital abnormalities. Obstet Gynec. submitted
40. Czeizel AE. Ten years of experience in periconceptional care. Eur J Obstet Gynec Reprod Biol. 1999 84 :43-49
41. Acs N, Puho E, Bánhidy F, Czeizel AE. Association between bronchial asthma in pregnancy and shorter gestational age in a population-based study. J Mater Fetal Neonat Med. Submitted
42. Vallance P. Drugs and the fetus. Brit Med J. 1996 312 :1053-1054
43. Czeizel AE. Analysis of medical indications for induced abortions. Orvosi Hetilap. 1983 124 :1297-1302
44. Czeizel AE, Métneki J. Evaluation of counselling for pregnant women exposed to potentially hazardous environmental factors. Acta Paediat Hung. 1985 26 :175-186
45. Czeizel AE, Intody Z, Modell B. What proportion of congenital abnormalities can be prevented?. Brit Med J. 1993 306 :499-503
46. Nielsen GL, Norgaard B, Puho E, at al. Risk of specific congenital abnormalities in offspring of women with diabetes. Diabet Medicine. 2005 22 :693-696
47. Czeizel AE, Toth M, Rockenbauer M. No teratogenic effect after clotrimazole therapy during pregnancy. Epidemiology. 1999 10 :437-440
48. Czeizel AE, Dudás I. Prevention of the first occurrence of neural-tube defects by periconceptional vitamin supplementation. N Engl J Med. 1992 327 :1832-1835
49. Czeizel AE. Prevention of congenital abnormalities by periconceptional multivitamin supplementation. Brit J Med. 1993 306 :1645-1648
50. Czeizel AE. Reduction of urinary tract and cardiovascular defects by periconceptional multivitamin supplementation. Am J Med Genet. 1996 62 :179-183
51. Czeizel AE, Dobo M, Vargha P. Hungarian cohort-controlled trial of periconceptional multivitamin supplementation shows a reduction in certain congenital abnormalities. Birth Defects research (Part A). 2004 70 :853-861
52. Taruscio D. Folic acid: from research to public health practice. Report of WHO Regional Office for Europe and the Instituto Superiore di Sanita. November 11-12, 2002 Rome